The global biopsy devices market size was USD 2.29 billion in 2023, estimated at USD 2.45 billion in 2024 and is anticipated to reach around USD 4.89 billion by 2034, expanding at a CAGR of 7.15% from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Biopsy Devices Market
5.1. COVID-19 Landscape: Biopsy Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Biopsy Devices Market, By Application
8.1. Biopsy Devices Market Revenue and Volume, by Application, 2024-2034
8.1.1. Needle-based Biopsy Guns
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Biopsy Guidance Systems
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Biopsy Forceps
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Biopsy Needles
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 9. Global Biopsy Devices Market, By End Use
9.1. Biopsy Devices Market Revenue and Volume, by End Use, 2024-2034
9.1.1. Hospitals
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Clinics
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 10. Global Biopsy Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.1.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.5.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, by End Use (2021-2034)
Chapter 11. Company Profiles
11.1. Medtronic plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton, Dickinson, and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hologic, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Boston Scientific Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Olympus Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. C. R. Bard, Inc. (acquired by BD)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Cook Medical LLC
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. FUJIFILM Holdings Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Mauna Kea Technologies
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Devicor Medical Products, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample